Business Of Biotech cover image

Multimodal R&D Management with Incyte's Jim Lee, M.D., Ph.D.

Business Of Biotech

CHAPTER

Advancements in Dermatology and Future Plans

The speakers discuss their collaboration in dermatology, including the approval of a topical Jack inhibitor and their ongoing focus on developing Ruxelletnib cream for various indications, as well as their plans to broaden their scope in treating inflammatory skin disorders and diseases.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner